-5%
Rabeprazole selectively inhibits the gastric H⁺/K⁺-ATPase enzyme (the proton pump) on the secretory surface of parietal cells, resulting in a marked reduction of gastric acid secretion. By blocking this enzyme, Rabeprazole effectively decreases acidity in the stomach, supporting ulcer healing and symptom relief in acid-related disorders.
Xorel MUPS 20 mg gastro-resistant tablets (Rabeprazole) are indicated for:
- Active duodenal ulcers
- Active benign gastric ulcers
- Symptomatic gastroesophageal reflux disease (GERD), including erosive or ulcerative forms
- Long-term management of GERD (maintenance therapy)
- Moderate to severe symptomatic GERD
- Zollinger-Ellison syndrome
- Helicobacter pylori eradication as part of combination therapy for peptic ulcer disease